The Trip Treatment: Psychedelics in Psychotherapy

TL;DR: Three conditions — terminal cancer anxiety, addiction, and depression — all show dramatic, durable responses to psilocybin-assisted therapy, and in each case the mechanism turns out to be the same: dissolve the ego, and the prison walls come down.

Spoilers through Chapter 7 (Chapter Six). Includes descriptions of terminal illness experiences and addiction recovery.

---

Chapter in one sentence

Pollan surveys the three clinical application areas driving the psychedelic renaissance — dying, addiction, and depression — and finds, in each, that the therapeutic benefit flows from the same source: the temporary dissolution of the self.

What happens

The chapter is the book's longest and most data-rich, and it's structured in three movements.

One: Dying. At NYU and Johns Hopkins, researchers Tony Bossis, Stephen Ross, and Bill Richards have been running psilocybin trials with terminal cancer patients experiencing existential distress. The results are striking: 80% of participants show clinically significant reductions in anxiety and depression after a single session, with effects persisting six months or more. These are not sedated patients — they are patients who have had a profound shift in how they understand their situation. The experiences they describe involve what the researchers call "embeddedness": instead of a frightened individual alone facing death, they feel woven into something vast and loving. Death remains true; the terror changes.

Two: Addiction. Matthew Johnson at Hopkins has been running a psilocybin-assisted smoking cessation study. The results at six months: 80% abstinence. At one year: 67%. For context, the best existing pharmacological treatment achieves roughly 35% at six months. The mechanism, in Johnson's account, is a perspective shift: psilocybin briefly provides a view from outside the habit story, and from that vantage point, the story looks optional. "Smoking became irrelevant, so I stopped," one volunteer reports. Not a decision — a realization.

Three: Depression. Rosalind Watts at Imperial College London has been working with treatment-resistant depression. She identifies two master themes in her patients: disconnection (from people, from themselves, from nature, from feeling) and entrapment (in the endless loops of a ruminating mind). Psilocybin, she finds, temporarily lifts both. Patients describe it as a "defrag" or "reboot" — the stuck record suddenly able to skip. The DMN loops loosen. The story of "I am someone who cannot be happy" briefly loses its authority.

The chapter closes with a coda: Pollan himself undergoes a supervised session at Imperial College to meet his own Default Mode Network.

Key moments

Patrick Mettes (NYU cancer trial) — A terminal patient who, after his session, describes a sense of being embedded in something larger: "It wasn't my death — it was part of something." The terror hasn't gone; the isolation has.

Bill Richards's flight instructions — The guidance Richards gives to patients before their sessions: "Trust and let go. Whatever comes, let it come." Short, actionable, everything.

Alice O'Donnell's abstinence — A smoking cessation participant who looks at a cigarette after her session and finds it simply doesn't belong to who she turned out to be. Not willpower. Perspective.

Rosalind Watts's landscape interviews — Asking depressed patients to describe their illness as a landscape: "A grey fog," "a prison," "underwater, watching through glass." The images are remarkably consistent. The cage is made of self-narrative.

The 80% abstinence chart — Johnson's smoking cessation results against every other treatment. The gap is not incremental — it is structural.

Why it matters

Chapter 6 is the book's payoff. History, neuroscience, personal experience — all of it has been building to this: evidence that carefully guided psilocybin sessions are producing clinical results across multiple conditions that no existing treatment can match, with a mechanism that makes theoretical sense. The chapter is also careful about the limits: single-session treatment, trained guides, specific conditions, early-stage data. This is not a cure-all. It is a door.

Themes to notice

• The prison of self-narrative — Across dying, addiction, and depression, the therapeutic mechanism is the same: loosening the self's grip on a story that has become a trap.
• Judging by fruits, not metaphysics — The book adopts William James's principle: evaluate an experience by what it produces, not by whether its metaphysical claims are verifiable.

Book club questions

1. The cancer patients in the book don't lose their knowledge of their diagnosis after the psilocybin session — they lose the terror. What does it say about fear that it can be addressed experientially but not informationally?
2. The smoking cessation participant described her habit as "irrelevant" rather than something she decided to stop. What's the difference — therapeutically and philosophically — between deciding to change and simply finding that you have?
3. Rosalind Watts describes depression as both disconnection and entrapment. If those are the core features, why do antidepressants (which target neurotransmitter balance) help some people but leave others unchanged?

Visual memory hook

A patient lying still, eyes closed, soft light through a window. Around them, the walls of a carefully appointed therapy room dissolve quietly at the edges. Through the gaps: not a hospital hallway but sky. The prison door, opening inward.